Drug Profile
Research programme: eye disorder therapeutics - InSite Vision
Alternative Names: BromDex; Bromfenac/dexamethasone ophthalmic - InSite Vision; ISV-102; ISV-215; ISV-504Latest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator InSite Vision
- Class Fluorinated steroids; Glucocorticoids; Pregnadienetriols; Prostaglandins; Small molecules; Tetracyclines
- Mechanism of Action Cyclooxygenase inhibitors; Glucocorticoid receptor agonists; Immunosuppressants; Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glaucoma; Ocular inflammation; Ocular pain; Ophthalmic infections
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for research development in Ocular-inflammation in USA (Ophthalmic, Drops)
- 28 Feb 2018 No recent reports of development identified for research development in Ocular-pain in USA (Ophthalmic, Drops)
- 16 Jul 2016 No recent reports of development identified for research development in Glaucoma in USA (Ophthalmic, Drops)